Jackson, C. B., Noorbakhsh, S. I., Sundaram, R. K., Kalathil, A. N., Ganesa, S., Jia, L., . . . Bindra, R. S. (2019). Temozolomide Sensitizes MGMT-Deficient Tumor Cells to ATR Inhibitors. Cancer research (Chicago, Ill.), 79(17), 4331-4338. https://doi.org/10.1158/0008-5472.CAN-18-3394
Chicago Style (17th ed.) CitationJackson, Christopher B., et al. "Temozolomide Sensitizes MGMT-Deficient Tumor Cells to ATR Inhibitors." Cancer Research (Chicago, Ill.) 79, no. 17 (2019): 4331-4338. https://doi.org/10.1158/0008-5472.CAN-18-3394.
MLA (9th ed.) CitationJackson, Christopher B., et al. "Temozolomide Sensitizes MGMT-Deficient Tumor Cells to ATR Inhibitors." Cancer Research (Chicago, Ill.), vol. 79, no. 17, 2019, pp. 4331-4338, https://doi.org/10.1158/0008-5472.CAN-18-3394.